Abstract

Thicker struts affording a smaller minimum in-stent diameter are known predictors of restenosis in coronary stents. The Slovakia Registry aimed to assess safety and efficacy of the ultrathin (60 μm) biodegradable polymer-coated Supraflex sirolimus-eluting stents (SES) (Sahajanand Medical Technologies Ltd., Surat, India), in an all-comers population with a subgroup of diabetic patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call